The Council for International Organizations of Medical Sciences (CIOMS) is an international, non-governmental, non-profit organization established jointly by WHO and UNESCO in 1949. CIOMS represents a substantial proportion of the biomedical scientific community through its member organizations, which include many of the biomedical disciplines, national academies of sciences and medical research councils. CIOMS mission is to advance public health through guidance on health research and policy including ethics, medical product development and safety. CIOMS is in official relations with WHO and is an associate partner of UNESCO.
2016 : New CIOMS Ethical Guidelines for Health-related research involving humans.
GOVERNANCE of CIOMS
The day-to-day management of CIOMS is carried out by the Secretariat in conformity with the directions of the Executive Committee. It consists of the Secretary-General and his/her team and is based in Geneva, Switzerland.
- The Executive Committee consists of up to twelve representatives chosen from among the International and National members.
- The Committee has full powers to act on behalf of the Association.
- Each member of the Committee has one vote and the President has a casting vote.
- In addition to the International, National and Associate members, the Committee may invite ad hoc observers and technical experts without the right to vote.
- The Committee appoints the Secretary-General.
- The Committee meets in person at least once a year (with teleconferences in between the meetings) and during every session of the General Assembly, and as often as the interests of the Association require.
- The General Assembly consists of all CIOMS members and meets in ordinary session every two years and the alternate years by teleconference. It can also be convened by the Executive Committee in special sessions.
- Normally the General Assembly adopts all its decisions by consensus. Only where a consensus cannot be reached for a decision does the Assembly proceed to voting where decisions are taken by a simple majority of the votes cast. Voting by proxy is not authorized.
- The General Assembly elects the members of the Executive Committee and the President.
- World Allergy Organization
- International College of Angiology
- International Society of Internal Medicine
- International Federation of Otorhinolaryngological Societies (IFOS)
- World Association of Societies of Pathology and Laboratory Medicine
- International Rhinologic Society
- Medical Womens International Association
- World Medical Association (WMA)
- International Society of Pharmacoepidemiology (ISPE)
- International Society of Pharmacovigilance (ISOP)
- International Union of Basic and Clinical Pharmacology (IUPHAR)
- International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP)
- Bangladesh Medical Research Council
- Royal Academy of Medicine of Belgium
- Czech Medical Association
- Association of the Scientific Medical Societies in Germany
- Georgian Society of Pharmacology
- Indian Council of Medical Research
- Israel Academy of Sciences and Humanities
- Korean Academy of Medical Sciences
- South African Medical Research Council
- Swiss Academy of Medical Sciences
- Medical Sciences Society (MSS-UQ) of Queensland University, Haiti
- Consulta di Bioetica
- American Society for Bioethics and Humanities
- European Association of Hospital Pharmacists
- World Federation of Chiropractic
- International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
- Good Clinical Practice Alliance
- World Organization of Family Doctors (WONCA)
- International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN)
- International Council for Laboratory Animal Science (ICLAS)
- World Association for Medical Law (WAML)
- Asia Pacific Academy of Ophthalmology (APAO)
- International Union of Physiological Sciences
- Federation of Polish Medical Organizations Abroad
- National Fund for Scientific Research
- International Medical Sciences Academy
- International Federation of Medical Students’ Associations (IFMSA)
- Saudi Neonatology Society
CIOMS Working Group
- Clinical research in resource-limited settings
- Drug-induced liver injury (DILI)
- Standardised MedDRA queries (SMQs)
- Vaccine safety
- Working Group X – Meta-analysis
- Working Group IX – Risk minimisation
- Working Group VIII – Signal detection
- Vaccine pharmacovigilance
Ongoing working groups
- MedDRA Labelling Groupings (MLGs)
- Working Group XI – Patient Involvement
- Working Group XIII
For more details: Click here